• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE

RECCE PHARMACEUTICALS LTD - Charts / Financials

0.00% ! 43.0¢
Market Cap $124.3M  !
Healthcare Biotechnology
Add to My Watchlist

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE COMMENCES PHASE 3 INDONESIAN TRIAL
refresh Created with Sketch. REFRESH
Last update - 16.10pm 10/03/2026 (20 minute delay) ?
Day
Open 42.5¢   Day High 45.0¢   Day Low 42.5¢
Daily Volume 119327
Bids   Sellers
Number Price Volume   Number Price Volume
0 43.0¢ 57373   0 44.0¢ 15076

Directors & Senior Management

Dr. Alan W. Dunton Chief Medical Advisor & Independent Non Executive Director
Mr. Alistair McKeough Independent Non-Executive Director
Mr. Arthur Kollaras Principal Engineer & Head of Manufacturing
Mr. Daniel Astudillo Head of Marketing
Mr. James Hamilton-Bray Graham CEO, MD & Executive Director
Dr. John K. A. Prendergast Executive Chairman of the Board
Mr. Justin Reynolds Chief Financial Officer
Dr. Justin Ward Principal Quality Chemist & Executive Director
Ms. Maggie Niewidok Company Secretary
Ms. Michele Keryn Dilizia Chief Scientific Director & Executive Director

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
43.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $124.3M
Open High Low Volume
42.5¢ 45.0¢ 42.5¢ 119.3K

Buyers (Bids)

Vol. Price($)
57373 43.0¢
 

Sellers (Offers)

Price($) Vol.
44.0¢ 15076
Last trade - 16.10pm 10/03/2026 (20 minute delay) ?

Top Stories

Listen: HotCopper Wire Podcast #044 – Operation Epic Fury

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson dive into the conflict in the Middle East, talking about the U.S-Israeli attacks on Iran, how the global situation is and will impact Australian shares, and what it might mean for our ongoing struggle with...
Paradigm chief Paul Rennie on IPPS blockbuster potential, 50% phase three milestone Welcome to the latest HotCopper Capital Compass, where we’ve this week spoken to Paradigm Biopharma (ASX:PAR) founder and managing director Paul Rennie about Paradigm arriving at its @pivotal” phase three trial, which will be examining outcomes of its flagshi...
Expert Exchange: Where to for Zip Co in 2026? The Trader vs the Journalist Here on HotCopper, we’re digging into our Expert Exchange series for CY26, tapping the greatest minds in the Australian finance and investment landscape for their two cents on what HotCopper users are dying to know.Listen to the HotCopper podcast for in-depth discussions and insig...
Syntara on advancing first-in-class Myelofibrosis therapy with multiple pipeline opportunities Welcome to the latest HotCopper Capital Compass, where we’ve this week spoken to Syntara Ltd (ASX:SNT) chief Gary Phillips for a high-level overview on the biotech company’s objectives in treating blood cancers and fibrosis, what underpins its value proposition, an...
As BHP battles China over iron prices – now Mongolia wants a word with Rio Tinto about copper Rio Tinto has found itself in a negotiation with the Mongolian gov't, not too unlike the situation in which BHP has found itself in recently.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.